Public Company News
ESMO Congress 2025 Presidential Symposium Oral Presentation | Disitamab Vedotin Achieves Major Breakthrough as First-Line Treatment for Urothelial Carcinoma
BERLIN, Oct. 20, 2025 /PRNewswire/ -- At the 2025 European Society for Medical Oncology (ESMO) Congress, a Phase III clinical study on disitamab vedotin plus toripalimab versus chemotherapy as first-line treatment for HER2-expressing locally advanced or metastatic urothelial carcinoma (RC48-C016)...
2025-10-20 14:58
1526
HD Hyundai Vice Chairman Chung Kisun Promoted to Chairman
SEOUL, South Korea, Oct. 20, 2025 /PRNewswire/ -- HD Hyundai announced that
Executive Vice ChairmanChung Kisun has been promoted to Chairman in its latest
executive appointments.
2025-10-20 14:24
1134
3M at China Wind Power 2025: innovations empowering the future of green energy
BEIJING, Oct. 20, 2025 /PRNewswire/ -- On October 20, 2025, 3M, a global leader in diversified technology, made its appearance at the 2025 China Wind Power (CWP 2025). At this year's exhibition, 3M's booth theme was "With Wind as Wings, 3M Empowers a Green Future," focusing on showcasing innovativ...
2025-10-20 14:16
1250
Agoda Spotlights Unique Asian Airports Redefining the Layover Experience
SINGAPORE, Oct. 20, 2025 /PRNewswire/ -- Digital travel platform Agoda has unveiled a list of five airports inAsia that transform layovers into memorable experiences. These airports offer more than just transit, with attractions that cater to both short and long stops, inviting travelers to arriv...
2025-10-20 14:03
1057
Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO
CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held inBerlin, Germany, Results from a Phase 3 study of the Company's human epidermal growth factor rece...
2025-10-20 13:59
1223
Biparatopic HER2-targeting ADC JSKN003 Was Granted Another Breakthrough Therapy Designation for HER2-Positive Advanced Colorectal Cancer
SUZHOU, China, Oct. 20, 2025 /PRNewswire/ -- October 20, 2025- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 has been granted another breakthrou...
2025-10-20 13:21
1165
Alphamab Oncology Presented Multiple Clinical Data on Biparatopic HER2-targeting ADC JSKN003 at ESMO Congress 2025
SUZHOU, China, Oct. 20, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that two latest clinical data on biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 for the treatment of primary platinum-refractory ovarian cancer (OC) and HER2-positive metastatic colore...
2025-10-20 13:15
1280
Zeekr Group to Report Third Quarter 2025 Financial Results on November 17, 2025
HANGZHOU, China, Oct. 20, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced that it will report its unaudited financial results for the third quarter endedSeptember 3...
2025-10-20 13:00
1531
KLN Drives Libya's Wellhead Platform A Project Toward Completion, One of the Mediterranean Sea's Largest Offshore EPCI Projects to Bolster Energy Infrastructure
HONG KONG, Oct. 20, 2025 /PRNewswire/ -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK), through its division KLN Project, today announced significant progress on the Wellhead Platform A (WHPA) project inLibya's Bahr Essalam field. As consortium leader appointed by Mellitah Oil & Gas Co...
2025-10-20 12:29
1152
Nongshim Shin Ramyun Light Ups New York Times Square with 'KPop Demon Hunters'
- Global campaign celebrates the U.S. debut of the movie-inspired collaboration package - NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Nongshim carried out a global campaign at New York Times Square to celebrate the launch of Shin Ramyun in collaboration with Netflix's hit animated film 'KPop Demon H...
2025-10-20 11:23
1215
Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM
CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held inBerlin, Germany, results from a Phase 3 OptiTROP-Lung04 trial of the Company's trophoblast cell-s...
2025-10-20 10:36
1253
Agoda and Premier Inn Partner to Capture Rising Asian Traveler Interest in UK and Europe
The partnership aims to connect travelers from Asia and beyond to over 900 properties across the UK,Germany and Ireland SINGAPORE, Oct. 20, 2025 /PRNewswire/ -- Global digital travel platform Agoda has announced a new partnership with theUnited Kingdom's (UK) largest hotel chain Premier Inn maki...
2025-10-20 10:30
1325
Save Now, Travel through March: T'way Air Announces Fall Savings to Korea
Promo Code FLYOCT & Special Coupons for Travel through March 2026
TAIPEI, Oct. 20, 2025 /PRNewswire/ -- T'way Air, Korea's leading low-cost
carrier, invites travelers to enjoy special savings throughOctober 31 on
Taiwan-Korea bookings for travel untilMarch 28, 2026.
2025-10-20 09:00
1234
Antengene Presents Latest ATG-022 Clinical Data at ESMO 2025 Demonstrating Efficacy Across All CLDN18.2 Expression Levels and Exceptional Tolerability
SHANGHAI and HONG KONG, Oct. 20, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematologic ma...
2025-10-20 09:00
1157
CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025
SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the research results of the Phase Ib registrational clinical trial of satricabtagene autoleucel ("satri-cel", CT041)...
2025-10-20 08:15
1353
ESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)
SUZHOU, China, Oct. 19, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced the first disclosure...
2025-10-20 08:10
1216
Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity
- The 12-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of the once-monthly subcutaneous (SQ) depot formulation (treatment formulation) ofsmall molecule GLP-1 receptor (GLP-1R) agonist ASC30 in 65 participants with obesity or overweight. - The ult...
2025-10-20 08:10
1469
Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd.
2025-10-20 07:00
1231
Webull Reduces Minimum ASX Trading Fee To $1
* Webull Australia now offers the lowest-cost CHESS-sponsored brokerage fee minimums for trading ASX shares * The new pricing structure is paired with Webull's industry-leading technology and free live pricing data * $1.00 minimum fees will be made available to Australian clients from 20 Oc...
2025-10-20 06:00
2084
Significant OS Benefit with Cadonilimab in First-Line Advanced Gastric Cancer: Final Analysis of COMPASSION-15 Presented at ESMO 2025
HONG KONG, Oct. 19, 2025 /PRNewswire/ -- On October 19, 2025, Akeso (9926.HK) announced the final analysis results from the COMPASSION-15/AK104-302 study at the 2025 European Society of Medical Oncology Congress (ESMO 2025) . COMPASSION-15 is a Phase III clinical trial evaluating cadonilimab, Ak...
2025-10-19 23:42
1575
Week's Top Stories
Most Reposted
Visa Supports Chinese Cardholders to Add Cards to Apple Pay for a More Convenient and Secure Payment Experience
[Picked up by 311 media titles]
2026-01-15 13:00Colebrook Bosson Saunders Launches Lana: An Adaptable Laptop Stand Engineered for Hybrid Work
[Picked up by 305 media titles]
2026-01-12 16:16
Ready Server Announces Strategic Expansion into Japan with AT TOKYO Data Centre
[Picked up by 301 media titles]
2026-01-13 13:16
CAYIN AI: Revolutionizing Creativity and Global Communication
[Picked up by 300 media titles]
2026-01-12 16:34
JIOS Aerogel® Secures Hyundai Contract Through New Licensing Model
[Picked up by 299 media titles]
2026-01-15 10:00Most Read
CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh
2026-01-11 04:10
4690
Rich Sparkle Holdings Closes Acquisition of TikTok Icon Khaby Lame's Core Company
2026-01-12 04:50
3844
